Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email email@example.com.
Check back regularly for news, coverage, and announcements about MAVA.
Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it closed a $12.15 million term loan with Mason Health.
Videology Inc., which has developed a sophisticated video platform to help advertisers shift from television to the Internet, has completed a $68.3 million Series D financing round led by Catalyst Investors.
Cartiva, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that the Company has secured $4.3 million in financing led by New Enterprise Associates (NEA).
HyTrust, a Silicon Valley-based developer of cloud security tools for virtual infrastructure, said on Monday it has landed a new investment as part of a larger technology development deal with In-Q-Tel (IQT), the Arlington-based venture fund backed by the Central Intelligence Agency (CIA).
Washington, DC ranks No. 6 on Entrepreneur's new list of the "Top Startup Cities -- By Cost & Taxes." The rankings, compiled by tax-planning startup GoodApril, consider factors such as median tech wages, taxes, housing costs and the cost of office space.
TroopSwap. Troop ID. ID.me. The ever-changing name of the Tysons Corner company co-founded by Blake Hall and Matthew Thompson provides a visible reminder of how the start-up has evolved and expanded its focus since being formed more than three years ago.
Riskive Inc. has raised $2.2 million via sale of shares to 14 investors, according to an SEC filing.
Tivli, an innovative IP-based service that delivers television to university students on their devices anywhere on campus, announced the completion of a $6.3 million Series A financing.
CVRx, Inc., a private medical device company, has completed a private equity financing totaling $29.6 million. CVRx plans to use the funding for the primary purposes of advancing its clinical trials and expanding its international commercial activities. New Enterprise Associates, Inc. (NEA) and Johnson & Johnson Development Corporation were the co-lead investors.
In Celebration of 30 Years in Business, Company Kicks Off Series of Community Service Events Around the World